Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence Study of 10 mg Alfuzosin Hydrochloride Prolonged-release Tablets in Healthy Thai Male Volunteers under Fasting Conditions
TCTR20170222003Phase 4Not yet recruiting
- Sponsor
- Research and Development
- Start
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of alfuzosin in benign prostatic hyperplasia (BPH), sponsored by Research and Development. Planned start Mar 2017; status: not yet recruiting.
02
Drugs
alfuzosin
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on TCTR20170222003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20170222003.